Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer
Abstract We investigated the combined effects of ataxia telangiectasia and Rad3-related (ATR) inhibition, ablative radiotherapy, and immune checkpoint inhibitor (ICI) therapy against lung cancer. ATR inhibitor was administered combined with ablative radiotherapy to assess its radiosensitizing effect...
主要な著者: | , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Springer
2024-11-01
|
シリーズ: | Cancer Immunology, Immunotherapy |
主題: | |
オンライン・アクセス: | https://doi.org/10.1007/s00262-024-03864-6 |